B-cell targeted therapy is associated with severe COVID-19 among patients with inflammatory arthritides: a 1-year multicentre study in 1116 successive patients receiving intravenous biologics.

Renaud FeltenPierre-Marie DuretElodie BauerNathanael SedmakJulien H DjossouMassiva BensalemMarc ArdizzoneMarion GeoffroyAngelique FanMarion CoudercJean Hugues SalmonLaurent MesserRose-Marie JavierAlain MeyerEmmanuel ChatelusChristelle SordetLuc PijnenburgJérémy FortMarina RinagelJulia WaltherCassandre FabreLaurent ArnaudJean SibiliaNicolas MeyerFrancis BerenbaumIsabelle Chary-ValckenaereMartin SoubrierJérémie SellamJacques-Eric Gottenberg

Published in: Annals of the rheumatic diseases (2021)

Keyphrases

coronavirus disease
sars cov
high dose
oxidative stress
early onset
respiratory syndrome coronavirus
drug induced
low dose